M. Eefting

Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL

M. Eefting, Constantijn J.M. Halkes, L. C. de Wreede et al. · Bone Marrow Transplantation · 2013 · 42 citations

Medicine, Hematology, Immunology +10

Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusion

M. Eefting, Liesbeth C. de Wreede, Constantijn J.M. Halkes et al. · Haematologica · 2016 · 40 citations · Full text

Medicine, Hematology, Immunology +14

Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib

Emanuele Ammatuna, M. Eefting, Kirsten van Lom et al. · Annals of Hematology · 2014 · 32 citations

Medicine, Hematology, Oncology +10

Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell transplantation

M. Eefting, Peter A. von dem Borne, L. C. de Wreede et al. · Haematologica · 2013 · 25 citations · Full text

Medicine, Hematology, Oncology +15

Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of <i>ITGB2</i>

Margot J. Pont, Dyantha I. van der Lee, Edith D. van der Meijden et al. · Clinical Cancer Research · 2016 · 16 citations

Life Sciences, Hematology, Immunology +17